Singapore Biosimilars Market (2024-2030) Outlook | Growth, Industry, Trends, Revenue, Companies, Size, Share, Forecast, Analysis, Value

Name: Singapore Biosimilars Market (2021 - 2027) | Trends, Outlook & Forecast
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy
Keywords: Biosimilars Market, Singapore Biosimilars Market, Singapore Biosimilars Market Revenues, Singapore Biosimilars Market Share, Singapore Biosimilars Market Size, Singapore Biosimilars Market Outlook, Singapore Biosimilars Market Report, Singapore Biosimilars Market Competition, Singapore Biosimilars Market Overview, Singapore Biosimilars Market Trends, Singapore Biosimilars Market Forecast

Market Forecast By Product (Insulin, Follitropin, Calcitonin, Glucagon, Teriparatide, Others), By Indication (Oncology, Offsite Treatment, Chronic Disorders, Blood Disorders, Infectious Diseases, Others), By Manufacturing (Outsourced, In-house) And Competitive Landscape

Product Code: ETC069946	Publication Date: Jul 2023	Updated Date: Jan 2024	Product Type: Report
Publisher: 6Wresearch	Author: Ravi Bhandari	No. of Pages: 70	No. of Figures: 35	No. of Tables: 5

Singapore Biosimilars Market Synopsis

Biosimilars are biologic drugs that are highly similar to existing approved biologic drugs (known as reference or originator biologics). They are developed to be as safe and effective as the reference biologics and are used to treat various medical conditions, including autoimmune diseases, cancer, and other chronic illnesses. The biosimilars market aims to provide more affordable and accessible treatment options while maintaining similar therapeutic outcomes.

Market Drivers

Cost Savings: Biosimilars are typically more cost-effective than their reference biologics, making them an attractive option for healthcare systems aiming to reduce treatment costs.Patent Expiries: The expiration of patents for many biologic drugs creates opportunities for the development and launch of biosimilars.Government Support: Governments in Singapore and other countries may actively encourage the adoption of biosimilars to improve healthcare affordability and access.Expanding Therapeutic Areas: The development of biosimilars is expanding to include various therapeutic areas, increasing the potential market size.

Market challenges

Complexity and Development Costs: Developing biosimilars involves complex processes and high development costs, which may deter some manufacturers from entering the market.Regulatory Requirements: Biosimilars must undergo rigorous regulatory evaluation and demonstrate similarity to reference biologics, adding to the time and cost of bringing them to market.Physician and Patient Confidence: Building confidence among healthcare providers and patients in the safety and efficacy of biosimilars can be a challenge.

Key players

The Singapore Biosimilars Market may have included:Amgen Inc., Celltrion Inc., Pfizer Inc., Biocon Limited

Covid-19 Impact

The Covid-19 pandemic may have had mixed impacts on the Singapore Biosimilars Market. While the focus on healthcare and treatment during the pandemic may have highlighted the importance of affordable treatment options like biosimilars, disruptions in healthcare systems could have affected the adoption and uptake of biosimilars.

Key Highlights of the Report:

Singapore Biosimilars Market Outlook
Market Size of Singapore Biosimilars Market, 2020
Forecast of Singapore Biosimilars Market, 2027
Historical Data and Forecast of Singapore Biosimilars Revenues & Volume for the Period 2023 - 2027
Singapore Biosimilars Market Trend Evolution
Singapore Biosimilars Market Drivers and Challenges
Singapore Biosimilars Price Trends
Singapore Biosimilars Porter's Five Forces
Singapore Biosimilars Industry Life Cycle
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Product for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Insulin for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Follitropin for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Calcitonin for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Glucagon for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Teriparatide for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Others for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Indication for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Oncology for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Others for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Manufacturing for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By Outsourced for the Period 2023 - 2027
Historical Data and Forecast of Singapore Biosimilars Market Revenues & Volume By In-house for the Period 2023 - 2027
Singapore Biosimilars Import Export Trade Statistics
Market Opportunity Assessment By Product
Market Opportunity Assessment By Indication
Market Opportunity Assessment By Manufacturing
Singapore Biosimilars Top Companies Market Share
Singapore Biosimilars Competitive Benchmarking By Technical and Operational Parameters
Singapore Biosimilars Company Profiles
Singapore Biosimilars Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Singapore Biosimilars Market Overview

3.1 Singapore Country Macro Economic Indicators

3.2 Singapore Biosimilars Market Revenues & Volume, 2020 & 2027F

3.3 Singapore Biosimilars Market - Industry Life Cycle

3.4 Singapore Biosimilars Market - Porter's Five Forces

3.5 Singapore Biosimilars Market Revenues & Volume Share, By Product, 2020 & 2027F

3.6 Singapore Biosimilars Market Revenues & Volume Share, By Indication, 2020 & 2027F

3.7 Singapore Biosimilars Market Revenues & Volume Share, By Manufacturing, 2020 & 2027F

4 Singapore Biosimilars Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Singapore Biosimilars Market Trends

6 Singapore Biosimilars Market, By Types

6.1 Singapore Biosimilars Market, By Product

6.1.1 Overview and Analysis

6.1.2 Singapore Biosimilars Market Revenues & Volume, By Product, 2018 - 2027F

6.1.3 Singapore Biosimilars Market Revenues & Volume, By Insulin, 2018 - 2027F

6.1.4 Singapore Biosimilars Market Revenues & Volume, By Follitropin, 2018 - 2027F

6.1.5 Singapore Biosimilars Market Revenues & Volume, By Calcitonin, 2018 - 2027F

6.1.6 Singapore Biosimilars Market Revenues & Volume, By Glucagon, 2018 - 2027F

6.1.7 Singapore Biosimilars Market Revenues & Volume, By Teriparatide, 2018 - 2027F

6.1.8 Singapore Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.2 Singapore Biosimilars Market, By Indication

6.2.1 Overview and Analysis

6.2.2 Singapore Biosimilars Market Revenues & Volume, By Oncology, 2018 - 2027F

6.2.3 Singapore Biosimilars Market Revenues & Volume, By Offsite Treatment, 2018 - 2027F

6.2.4 Singapore Biosimilars Market Revenues & Volume, By Chronic Disorders, 2018 - 2027F

6.2.5 Singapore Biosimilars Market Revenues & Volume, By Blood Disorders, 2018 - 2027F

6.2.6 Singapore Biosimilars Market Revenues & Volume, By Infectious Diseases, 2018 - 2027F

6.2.7 Singapore Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.3 Singapore Biosimilars Market, By Manufacturing

6.3.1 Overview and Analysis

6.3.2 Singapore Biosimilars Market Revenues & Volume, By Outsourced, 2018 - 2027F

6.3.3 Singapore Biosimilars Market Revenues & Volume, By In-house, 2018 - 2027F

7 Singapore Biosimilars Market Import-Export Trade Statistics

7.1 Singapore Biosimilars Market Export to Major Countries

7.2 Singapore Biosimilars Market Imports from Major Countries

8 Singapore Biosimilars Market Key Performance Indicators

9 Singapore Biosimilars Market - Opportunity Assessment

9.1 Singapore Biosimilars Market Opportunity Assessment, By Product, 2020 & 2027F

9.2 Singapore Biosimilars Market Opportunity Assessment, By Indication, 2020 & 2027F

9.3 Singapore Biosimilars Market Opportunity Assessment, By Manufacturing, 2020 & 2027F

10 Singapore Biosimilars Market - Competitive Landscape

10.1 Singapore Biosimilars Market Revenue Share, By Companies, 2020

10.2 Singapore Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Biosimilars Market

Asia Biosimilars Market

Asia Pacific Biosimilars Market

Cameroon Biosimilars Market

Canada Biosimilars Market

Cape Verde Biosimilars Market

Chad Biosimilars Market

Comoros Biosimilars Market

Europe Biosimilars Market

Global Biosimilars Market

North America Biosimilars Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here